Csam Health Group AS
F:6Q1
Csam Health Group AS
F:6Q1
Price:
3.41
EUR
-2.01%
Market Closed
Market Cap:
€69.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Csam Health Group AS
F:6Q1
|
NO |
|
Indal Aluminium Industry Tbk PT
IDX:INAI
|
ID |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 6Q1.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6Q1
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
6Q1 Competitors Multiples
Csam Health Group AS Competitors
Csam Health Group AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
|
Csam Health Group AS
F:6Q1
|
830.7m EUR | 2.1 | -7.8 | 65.5 | -14.8 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | 21.9 | 43.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.8B USD | 9 | 31.7 | 22.6 | 23.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12B AUD | 49.2 | 52.1 | 64.4 | 64.4 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.2 | 21.9 | 10.8 | 13.1 | |
| SE |
|
Sectra AB
STO:SECT B
|
43B SEK | 18.4 | 80.1 | -110.4 | -110.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.5B USD | 4 | 39.2 | 14.3 | 21.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 6.9 | 18.3 | 14.5 | 15.3 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | 267.9 | 4 290.1 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 8.6 | -60.7 | -120.1 | -120.1 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
227.9B INR | 7.4 | 34.4 | 22.7 | 25.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
